Sector portfolio · Hedge fund · United States

Rock Springs Capital's Biotech portfolio

Rock Springs Capital has backed 15 Biotech startups in rounds we track, $3.4B between them, shown by the stage each has reached. The best-funded is Kymera Therapeutics.

15startups backed
2stages
$3.4Braised between them
Series C and laterbiggest stage

Rock Springs Capital's profile

Series C and later

10

Series B

5

Segment by segment

Series C and later

10 startups · $2.5B raised

  1. Kymera TherapeuticsKymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.United States$799M
  2. Apollo TherapeuticsApollo Therapeutics is a biopharmaceutical company focused on developing innovative medicines by translating fundamental medical rUnited Kingdom$400M
  3. Coherus BiosciencesCoherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.United States$299M
  4. Imperative CareImperative Care is a medical technology company based in Campbell, California, focused on developing innovations for patients withUnited States$196M
  5. DDermiraDermira is a development-stage biotech company focused on developing and commercializing innovative new therapies in dermatology.United States$169M
  6. Mersana TherapeuticsMersana Therapeutics develops a biodegradable polymer platform Fleximer® which creates new and better medicines.United States$148M
  7. 3B3-V BiosciencesUnited States$146M
  8. Vedanta BiosciencesVedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.United States$143M

Series B

5 startups · $945M raised

  1. CTCidara TherapeuticsCidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics.United States$463M
  2. CTCity TherapeuticsUnited States$235M
  3. Vigil NeuroscienceVigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.United States$130M
  4. Ra PharmaceuticalsRa Pharma is developing Cyclomimetics, a new drug class combining the properties and benefits of antibodies and small molecules.United States$77M
  5. Nivalis TherapeuticsNivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.United States$40M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Rock Springs Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Co-investorsWho invests with Rock Springs Capital28 co-investorsSector portfolioMaverick Silicon's AI portfolio10 startups · $4.7BSector portfolioY Combinator's AI portfolio1,143 startups · $44BSector portfolioY Combinator's Fintech portfolio338 startups · $24BSector portfolioTechstars' AI portfolio336 startups · $4.9BSector portfolioAlumni Ventures' AI portfolio302 startups · $36B

Raising from investors like Rock Springs Capital?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps